Cridanimod
Tier C — Watch / tradeCridanimod
Targets：PR
Brand：Virexxa, Neovir, Camedon, Kamedon, Cycloferon
Indications (approved)：Respiratory tract infection, Influenza virus infection, Endometrial cancer
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| CRIDA-001 | 122-39-4 | diphenylamine |
| CRIDA-002 | 578-95-0 | acridin-9(10H)-one |
| CRIDA-003 | 38609-90-4 | ethyl 2-(9-oxoacridin-10(9H)-yl)acetate |
| Cridanimod | 58880-43-6 | sodium 2-(9-oxoacridin-10(9H)-yl)acetate |
Frequently asked questions
What are the approved indications of Cridanimod?
Approved indications include: Respiratory tract infection, Influenza virus infection, Endometrial cancer.
When does the Cridanimod patent expire?
No public expiry year is available for Cridanimod yet; this page updates once verified.
How many synthesis routes are recorded for Cridanimod?
1 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Cridanimod intermediates?
All intermediates in Cridanimod routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Cridanimod intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-02